Sanofi SA (SNY)
48.14
+0.32
(+0.67%)
USD |
NASDAQ |
Nov 15, 13:52
Sanofi Net Income (TTM): 4.927B for Sept. 30, 2024
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 4.927B |
| June 30, 2024 | 4.581B |
| March 31, 2024 | 4.947B |
| December 31, 2023 | 5.859B |
| September 30, 2023 | 9.638B |
| June 30, 2023 | 8.980B |
| March 31, 2023 | 8.667B |
| December 31, 2022 | 8.778B |
| September 30, 2022 | 6.911B |
| June 30, 2022 | 7.544B |
| March 31, 2022 | 7.736B |
| December 31, 2021 | 7.369B |
| September 30, 2021 | 14.42B |
| June 30, 2021 | 13.56B |
| March 31, 2021 | 12.04B |
| June 30, 2020 | 12.12B |
| March 31, 2020 | 3.655B |
| December 31, 2019 | 3.089B |
| September 30, 2019 | 3.447B |
| June 30, 2019 | 4.128B |
| March 31, 2019 | 5.135B |
| December 31, 2018 | 5.092B |
| September 30, 2018 | 4.933B |
| June 30, 2018 | 4.131B |
| March 31, 2018 | 4.362B |
| Date | Value |
|---|---|
| December 31, 2017 | 9.187B |
| September 30, 2017 | 9.909B |
| June 30, 2017 | 9.935B |
| March 31, 2017 | 10.10B |
| December 31, 2016 | 5.228B |
| September 30, 2016 | 4.741B |
| June 30, 2016 | 4.682B |
| March 31, 2016 | 4.813B |
| December 31, 2015 | 4.768B |
| September 30, 2015 | 6.075B |
| June 30, 2015 | 5.842B |
| March 31, 2015 | 5.469B |
| December 31, 2014 | 5.800B |
| September 30, 2014 | 5.571B |
| June 30, 2014 | 5.610B |
| March 31, 2014 | 5.129B |
| December 31, 2013 | 4.950B |
| September 30, 2013 | 4.009B |
| June 30, 2013 | 4.317B |
| March 31, 2013 | 5.212B |
| December 31, 2012 | 6.278B |
| September 30, 2012 | 7.652B |
| June 30, 2012 | 8.597B |
| March 31, 2012 | 8.566B |
| December 31, 2011 | 7.860B |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
3.089B
Minimum
Dec 2019
14.42B
Maximum
Sep 2021
8.046B
Average
7.640B
Median
Net Income (TTM) Benchmarks
| AstraZeneca PLC | 6.44B |
| Eli Lilly and Co | 8.370B |
| Pfizer Inc | 4.252B |
| Regeneron Pharmaceuticals Inc | 4.654B |
| Genfit SA | -- |